Shenzhen Tritek LimitedAgent Authorization • October 18th, 2022
Contract Type FiledOctober 18th, 2022
Agent Authorization LetterAgent Authorization • March 1st, 2022
Contract Type FiledMarch 1st, 2022
Agent Authorization LetterAgent Authorization • December 6th, 2021
Contract Type FiledDecember 6th, 2021We, authorize Micom Labs Inc., 575 Boulder Court, Pleasanton, California 94566, USA to act on our behalf in all matters relating to application for equipment authorization, including the signing of all documents relating to these matters.
Agent Authorization LetterAgent Authorization • September 18th, 2021
Contract Type FiledSeptember 18th, 2021
DECCON INTERNATIONAL LTD.Agent Authorization • January 2nd, 2020
Contract Type FiledJanuary 2nd, 2020
SHENZHEN ELECTRON TECHNOLOGY CO.,LTD.Agent Authorization • January 14th, 2022
Contract Type FiledJanuary 14th, 2022
Shenzhen Feihe Electronics Co., Ltd.Agent Authorization • November 9th, 2021
Contract Type FiledNovember 9th, 2021
Fatigue Science Technologies International Ltd.Agent Authorization • September 22nd, 2021
Contract Type FiledSeptember 22nd, 2021
Agent Authorization LetterAgent Authorization • April 6th, 2023
Contract Type FiledApril 6th, 2023
Shenzhen GOULY LED LIMITEDAgent Authorization • November 4th, 2022
Contract Type FiledNovember 4th, 2022
ACCOUNT ACCESS USING DIRECTLINE FOR BUSINESSAgent Authorization • August 7th, 2007 • Ontario
Contract Type FiledAugust 7th, 2007 JurisdictionReference is made to the DirectLine for Business Service Agreement dated , 200 between Bank of Montreal (referred to as “we”, “us” and “our”) and Agent (the “DirectLine Agreement”).
Agent Authorization LetterAgent Authorization • May 6th, 2023
Contract Type FiledMay 6th, 2023
Smart Devices Ltd.Agent Authorization • April 17th, 2024
Contract Type FiledApril 17th, 2024
Agent Authorization LetterAgent Authorization • August 6th, 2024
Contract Type FiledAugust 6th, 2024
AGENT AUTHORIZATIONAgent Authorization • November 2nd, 2021
Contract Type FiledNovember 2nd, 2021This is to advise that we are in full compliance with the Anti-Drug Abuse Act. The applicant is not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 U.S.C. 862, and no party to the application is subject to a denial of federal benefits pursuant to that section.
Autel Intelligent Tech. Corp., Ltd.Agent Authorization • September 29th, 2020
Contract Type FiledSeptember 29th, 2020
Hangzhou CareoMedic Tech Co.,Ltd.Agent Authorization • October 15th, 2018
Contract Type FiledOctober 15th, 2018